VEKADE PHARMA LIMITED
Significant control: Kanjikumar Bavanjibhai Mandanka (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Vekade Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Vekade Pharma Limited sell?
Registered activity: Other professional, scientific and technical activities n.e.c. (SIC 74909). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
VEKADE PHARMA LIMITED is an active private limited company (company number 07179980) incorporated on 5 March 2010, registered in Watford. Its registered activity is other professional, scientific and technical activities n.e.c. (SIC 74909). Latest small accounts cover the period ending 31 March 2025, showing net assets of £25k and cash of £14k, with 3 employees on average. Net assets rose 11% on the prior period (£23k).
By net assets it sits in the upper half of 3,982 comparable companies in Greater London (median £6,072, upper quartile £45k).
Ownership and control
- Mr Kanjikumar Bavanjibhai Mandanka
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 5 March 201016 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 19 March 2027in 146 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £25k | £14k | £79k | £148k | — | — | 3 |
| 31 March 2024 | £23k | £26k | £126k | £190k | — | — | 3 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £24,995 at 31 March 2025
- Net assets up 10% or more on the prior period+10.8% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.91
- Incorporated five or more years agoIncorporated 5 March 2010
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 146 days
- Next accounts duein 68 days
- Accounts period endNet assets £25k · small accounts
- Accounts period endNet assets £23k · small accounts
- Incorporated
Similar companies in Greater London
- OVERTONES 2 TUNE LIMITEDWaltham Cross · inc. Mar 2010
- WAVELENGTH DEVELOPMENT LTDEsher · inc. Mar 2010
- DT MED LIMITEDHarrow · inc. Mar 2010
- SSS CONSULTING LIMITEDBexleyheath · inc. Mar 2010
- THE ROBIN TUTTY CONSULTANCY LTDWatford · inc. Feb 2010
- PRAETORIAN CONSULTING LIMITEDThames Ditton · inc. Feb 2010
All companies incorporated on 5 March 2010 · in Mar 2010.
Reminders for VEKADE PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.